Safety and Efficacy Trial of Imexon Plus DTIC in Advanced Malignant Melanoma
Public ClinicalTrials.gov record NCT00327600. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1/2 Trial of Amplimexon® (Imexon, Inj.) Plus Dacarbazine (DTIC) in Chemotherapy Naive Patients With Unresectable Stage III or Stage IV Malignant Melanoma
Study identification
- NCT ID
- NCT00327600
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- AmpliMed Corporation
- Industry
- Enrollment
- 68 participants
Conditions and interventions
Conditions
Interventions
- imexon Drug
- DTIC Drug
Drug
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2005
- Primary completion
- Dec 31, 2006
- Completion
- Nov 30, 2007
- Last update posted
- Sep 14, 2010
2005 – 2007
United States locations
- U.S. sites
- 11
- U.S. states
- 10
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational Site 009 | Los Angeles | California | 90033 | — |
| Investigational Site 002 | Santa Monica | California | 90404 | — |
| University of CO Anschutz Cancer Pavilion | Aurora | Colorado | 80010 | — |
| US Oncology Orlando, Cancer Centers of FL | Ocoee | Florida | 34761 | — |
| US Oncology Albany, New York Oncology | Albany | New York | 12208 | — |
| US Oncology Kettering | Kettering | Ohio | 45409 | — |
| US Oncology Greenville, Cancer Centers of the Carolinas | Greenville | South Carolina | 29615 | — |
| US Oncology, Tyler Cancer Center | Tyler | Texas | 75702 | — |
| Investigational Site 012 | Salt Lake City | Utah | 84112 | — |
| US Oncology, Virginia Oncology Assoc | Norfolk | Virginia | 23502 | — |
| US Oncology Spokane, Cancer Care Northwest | Spokane | Washington | 99218 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00327600, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 14, 2010 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00327600 live on ClinicalTrials.gov.